| Dr David Richard Lough, MD | |
|
500 Donnally St Ste 200, Charleston, WV 25301-1600 | |
| (304) 767-7830 | |
| (304) 767-7829 |
| Full Name | Dr David Richard Lough |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 33 Years |
| Location | 500 Donnally St Ste 200, Charleston, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407855422 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 17615 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Hospital | Charleston, WV | Hospital |
| Thomas Memorial Hospital | South charleston, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ths Physician Partners Inc | 9537316393 | 135 |
News Archive
The spread of swine flu and other infectious diseases could be dramatically reduced by revolutionising the way that the places we live in are designed and built.
Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK) inhibitor abemaciclib (Verzenio) to standard adjuvant endocrine therapy continued to improve invasive disease-free survival (IDFS) among patients with high-risk, node-positive, early-stage, HR-positive, HER2-negative breast cancer, according to data presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.
Kiadis Pharma today provided an update on its cell therapy product ATIR™ developed for mismatched bone marrow transplants.
A recent review that examined all published studies on anatomical abnormalities in the brains of individuals with Autism Spectrum Disorder found substantial discrepancy throughout the literature regarding the reported presence and significance of neuroanatomical findings.
› Verified 6 days ago
| Entity Name | Ear Nose & Throat Assc Of Charl Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295735850 PECOS PAC ID: 7618918608 Enrollment ID: O20050519000915 |
News Archive
The spread of swine flu and other infectious diseases could be dramatically reduced by revolutionising the way that the places we live in are designed and built.
Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK) inhibitor abemaciclib (Verzenio) to standard adjuvant endocrine therapy continued to improve invasive disease-free survival (IDFS) among patients with high-risk, node-positive, early-stage, HR-positive, HER2-negative breast cancer, according to data presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.
Kiadis Pharma today provided an update on its cell therapy product ATIR™ developed for mismatched bone marrow transplants.
A recent review that examined all published studies on anatomical abnormalities in the brains of individuals with Autism Spectrum Disorder found substantial discrepancy throughout the literature regarding the reported presence and significance of neuroanatomical findings.
› Verified 6 days ago
| Entity Name | Ths Physician Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871866806 PECOS PAC ID: 9537316393 Enrollment ID: O20120829000738 |
News Archive
The spread of swine flu and other infectious diseases could be dramatically reduced by revolutionising the way that the places we live in are designed and built.
Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK) inhibitor abemaciclib (Verzenio) to standard adjuvant endocrine therapy continued to improve invasive disease-free survival (IDFS) among patients with high-risk, node-positive, early-stage, HR-positive, HER2-negative breast cancer, according to data presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.
Kiadis Pharma today provided an update on its cell therapy product ATIR™ developed for mismatched bone marrow transplants.
A recent review that examined all published studies on anatomical abnormalities in the brains of individuals with Autism Spectrum Disorder found substantial discrepancy throughout the literature regarding the reported presence and significance of neuroanatomical findings.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Richard Lough, MD 4605 Maccorkle Ave Sw, South Charleston, WV 25309-1311 Ph: (304) 414-4800 | Dr David Richard Lough, MD 500 Donnally St Ste 200, Charleston, WV 25301-1600 Ph: (304) 767-7830 |
News Archive
The spread of swine flu and other infectious diseases could be dramatically reduced by revolutionising the way that the places we live in are designed and built.
Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK) inhibitor abemaciclib (Verzenio) to standard adjuvant endocrine therapy continued to improve invasive disease-free survival (IDFS) among patients with high-risk, node-positive, early-stage, HR-positive, HER2-negative breast cancer, according to data presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.
Kiadis Pharma today provided an update on its cell therapy product ATIR™ developed for mismatched bone marrow transplants.
A recent review that examined all published studies on anatomical abnormalities in the brains of individuals with Autism Spectrum Disorder found substantial discrepancy throughout the literature regarding the reported presence and significance of neuroanatomical findings.
› Verified 6 days ago
Dr. Richard Austin Wallace, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1306 Kanawha Blvd E, Charleston, WV 25301 Phone: 304-343-4371 Fax: 304-353-0215 | |
Carrie Marie Bush, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 830 Pennsylvania Ave, Suite 405, Charleston, WV 25302 Phone: 304-388-2980 Fax: 304-388-2981 | |
Marcus Doddridge Shaffer, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 830 Pennsylvania Ave, Suite 302, Charleston, WV 25302 Phone: 304-388-2950 Fax: 304-388-2951 | |
Mr. Phillip Todd Nichols, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 Donnally St, Suite 200, Charleston, WV 25301 Phone: 304-342-0124 Fax: 304-340-2204 | |
Mr. Michael R Goins, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1311 Virginia St. E, Suite 200, Charleston, WV 25301 Phone: 304-353-0200 Fax: 304-353-0337 |